Albireo Pharma, Inc.
ALBO · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $248 | $251 | $132 | $164 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $3 | $0 | $0 | $3 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $17 | $11 | $10 | $1 |
| Total Curr. Assets | $269 | $262 | $142 | $168 |
| Property Plant & Equip (Net) | $1 | $0 | $1 | $0 |
| Goodwill | $17 | $17 | $17 | $17 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $15 | $6 | $5 | $0 |
| Total NC Assets | $33 | $24 | $23 | $18 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $302 | $286 | $165 | $185 |
| Liabilities | – | – | – | – |
| Payables | $7 | $5 | $5 | $4 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $39 | $20 | $14 | $8 |
| Total Curr. Liab. | $45 | $25 | $19 | $13 |
| LT Debt | $10 | $10 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $71 | $69 | $53 | $50 |
| Total NC Liab. | $81 | $79 | $53 | $50 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $126 | $104 | $72 | $63 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$301 | -$267 | -$159 | -$96 |
| AOCI | $1 | -$9 | $6 | $4 |
| Other Equity | $475 | $456 | $246 | $215 |
| Total Equity | $176 | $181 | $93 | $123 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $302 | $286 | $165 | $185 |
| Net Debt | -$238 | -$242 | -$132 | -$164 |